| Application no. and date | 06801867.0 (espacenet) (Federated) (European Patent Register), 20060818 | | Patent/reg. no. and date | DK/EP 1971362, 20141203 | | Publication date | 20080924 | | Priority no. and date | US 709604 P, 20050819, US 779216 P, 20060303 | | EP pub. no. and date |
EP 1971362 20080924 | | Effective date | | | Applicant/owner | Amylin Pharmaceuticals, LLC, 9360 Towne Centre Drive
San Diego, CA 92121, US,
AstraZeneca Pharmaceuticals LP, 1800 Concorde Pike
Wilmington, DE, US | | Applicant ref. no. | V103DKEP | | Inventor | FINEMAN, Mark, 9360 Towne Centre Drive
San Diego, CA 92121, US,
MACCONELL, Leigh, 9360 Towne Centre Drive
San Diego, CA 92121, US,
TAYLOR, Kristin, 9360 Towne Centre Drive
San Diego, CA 92121, US | | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 9/00 (2006.01) , A61P 3/04 (2006.01) , A61P 3/10 (2006.01) | | Title | Exendin til behandling af diabetes og reduktion af legemsvægt | | Int. application no. | US2006032354 | | Int. publication no. | WO2007024700 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
